与Atogepant相关的不良事件:基于FAERS的药监测分析
Ying Zhang1, Shengzhu Sun1, Yuming Wang2
1First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, PR China.
Expert opinion on drug safety
|September 6, 2024
概括
这项研究分析了FDA的数据,以确定与偏头痛预防药物阿托基潘特相关的不良事件 (AE). 这些发现支持加强对这种与色素基因相关的受体对手的临床监测.
科学领域:
- 药物监督 药物监督 药物监督
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
背景情况:
- 偏头痛是一种使人衰弱的神经血管疾病,影响日常生活.
- 阿托吉潘特是一种口服小分子素基因相关的受体对手,用于偏头痛预防.
- 了解atogepant的不良事件 (AEs) 对于患者的安全至关重要.
研究的目的:
- 调查与atogepant相关的不良事件 (AEs).
- 利用FDA不良事件报告系统 (FAERS) 的数据挖掘来获得安全见解.
- 为了提高atogepant的临床安全概况.
主要方法:
- 利用FAERS数据从2021年第三季度到2023年第四季度用于atogepant.
- 使用不成比例分析,特别是报告的比率比率 (ROR),以检测风险信号.
- 根据系统器官类 (SOC) 和使用MedDRA的首选术语 (PT) 分析了AE.
主要成果:
- 分析了7,991,243个FAERS报告,确定了3015个主要可疑的 (PS) 亚托基潘特的副作用.
- 在27个器官系统中观察到甲基诱导的副作用.
- 确定了48个明显不成比例的首选术语 (PT),符合所有分析标准.
结论:
- 鉴定了与阿托基潘特治疗相关的特定不良事件 (AE).
- 这些发现为临床监测阿托基潘特提供了有价值的支持.
- 有助于更好的风险识别和管理,用于阿托基潘特治疗.
相关概念视频
01:19Pharmacovigilance
789
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
789
01:20Antiepileptic Drugs: Potassium Channel Activators
150
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
150
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
499
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
499
01:14Agonism and Antagonism: Quantification
333
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
333
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
142
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
142
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K